Aquatic Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.3M | Buy |
52,025
+39,464
| +314% | +$20.7M | 0.55% | 37 |
|
|
2025
Q1 | $7.97M | Sell |
12,561
-14,520
| -54% | -$9.21M | 0.2% | 130 |
|
|
2024
Q4 | $19.3M | Buy |
27,081
+15,241
| +129% | +$10.9M | 0.52% | 44 |
|
|
2024
Q3 | $12.4M | Buy |
+11,840
| New | +$12.4M | 0.33% | 91 |
|
|
2024
Q1 | – | Sell |
-11,280
| Closed | -$9.91M | – | 1572 |
|
|
2023
Q4 | $9.91M | Buy |
+11,280
| New | +$9.91M | 0.25% | 102 |
|
|
2023
Q2 | – | Sell |
-2,500
| Closed | -$2.05M | – | 1681 |
|
|
2023
Q1 | $2.05M | Sell |
2,500
-5,700
| -70% | -$4.68M | 0.13% | 181 |
|
|
2022
Q4 | $5.92M | Buy |
+8,200
| New | +$5.92M | 0.43% | 46 |
|
|
2022
Q1 | – | Sell |
-100
| Closed | -$63K | – | 1447 |
|
|
2021
Q4 | $63K | Buy |
+100
| New | +$63K | 0.12% | 241 |
|